A novel 8.7-kb mitochondrial genome deletion accurately detects endometriosis in the plasma of symptomatic women

Biomark Med. 2020 Feb;14(2):97-107. doi: 10.2217/bmm-2019-0451. Epub 2019 Nov 29.

Abstract

Aim: To evaluate an 8.7-kb mitochondrial DNA (mtDNA) deletion as a potential biomarker of endometriosis. Materials & methods: We tested the diagnostic accuracy of the 8.7-kb deletion real-time PCR assay using 182 prospectively collected blood samples from females presenting with symptoms of endometriosis in a case-control format. Results: The assay differentiated between endometriosis and controls (area under curve: 0.74-0.89) with a statistically significant difference (p < 0.05) in 8.7-kb deletion levels measured for all disease subtypes and stages. No correlation was seen between 8.7-kb deletion levels and participant or specimen age, hormone status or menstrual phase. Conclusion: The diagnostic accuracy of the 8.7-kb deletion for endometriosis suggests potential utility in the clinic to improve patient management.

Keywords: DNA deletion; biomarker; diagnostic accuracy; endometriosis; mitochondrial DNA; molecular diagnostic; mtDNA; real-time PCR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • DNA, Mitochondrial / genetics*
  • Endometriosis / blood
  • Endometriosis / diagnosis
  • Endometriosis / genetics*
  • Female
  • Genome, Mitochondrial / genetics*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Polymerase Chain Reaction
  • Prospective Studies
  • Sensitivity and Specificity
  • Sequence Deletion*

Substances

  • DNA, Mitochondrial